-+ 0.00%
-+ 0.00%
-+ 0.00%

Dare Bioscience Q2 EPS $(0.45) Beats $(0.61) Estimate

Benzinga·08/14/2025 20:03:54
Listen to the news
Dare Bioscience (NASDAQ:DARE) reported quarterly losses of $(0.45) per share which beat the analyst consensus estimate of $(0.61) by 26.83 percent. This is a 129.61 percent decrease over earnings of $1.52 per share from the same period last year.